Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: Results from the Cardiovascular Health Study

T. L. Nelson, M. L. Biggs, Jorge Kizer, M. Cushman, J. E. Hokanson, C. D. Furberg, K. J. Mukamal

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Introduction: Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been consistently associated with cardiovascular disease (CVD) risk factors and predictive of CVD outcomes; furthermore, it is consistently higher among type 2 diabetics than nondiabetics. However, the relationships of circulating Lp-PLA2 mass and activity with incident type 2 diabetes mellitus have not been examined. Therefore, the purpose of this study was to determine the association of Lp-PLA2 mass and activity with type 2 diabetes among older adults. Methods: We conducted analyses of Lp-PLA2 and prevalent and incident diabetes among 5474 men and women from the Cardiovascular Health Study (1989-2007). Lp-PLA2 mass and activity were measured in baseline plasma. Diabetes status was ascertained annually with medication inventories and repeated blood glucose measurements. Generalized linear and Cox proportional hazards models were used to adjust for confounding factors including body mass index and inflammation. Results: At baseline, the top two quintiles of Lp-PLA2 activity were significantly associated with prevalent type 2 diabetes with a multivariable relative risk = 1.35 [95% confidence interval (CI) = 1.11-1.63] for quintile 4, and relative risk = 1.33 (95% CI = 1.07-1.66) for quintile 5. Among participants free of diabetes at baseline, we found a significant positive association with both the homeostatic model assessment for insulin resistance and β-cell function per sd increase in Lp-PLA2 activity (P values for both <0.01). In prospective analyses, the risk of incident type 2 diabetes was significantly higher among those in the highest quintile of Lp-PLA2 activity [multivariable hazard ratio = 1.45 (95% CI = 1.01-2.07)] compared with the lowest quintile. Lp-PLA2 mass was not significantly associated with incident type 2 diabetes. Discussion: Lp-PLA2 activity is positively associated with insulin resistance and predicts incident type 2 diabetes among older adults independent of multiple factors associated with diabetes pathogenesis.

Original languageEnglish (US)
Pages (from-to)1695-1701
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume97
Issue number5
DOIs
StatePublished - May 2012
Externally publishedYes

Fingerprint

1-Alkyl-2-acetylglycerophosphocholine Esterase
Medical problems
Type 2 Diabetes Mellitus
Health
Confidence Intervals
Insulin Resistance
Hazards
Cardiovascular Diseases
Insulin
Women's Health
Proportional Hazards Models
Lipoproteins
Blood Glucose
Body Mass Index

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes : Results from the Cardiovascular Health Study. / Nelson, T. L.; Biggs, M. L.; Kizer, Jorge; Cushman, M.; Hokanson, J. E.; Furberg, C. D.; Mukamal, K. J.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 97, No. 5, 05.2012, p. 1695-1701.

Research output: Contribution to journalArticle

Nelson, T. L. ; Biggs, M. L. ; Kizer, Jorge ; Cushman, M. ; Hokanson, J. E. ; Furberg, C. D. ; Mukamal, K. J. / Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes : Results from the Cardiovascular Health Study. In: Journal of Clinical Endocrinology and Metabolism. 2012 ; Vol. 97, No. 5. pp. 1695-1701.
@article{cd7c117c431347378ece1656c834b386,
title = "Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes: Results from the Cardiovascular Health Study",
abstract = "Introduction: Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been consistently associated with cardiovascular disease (CVD) risk factors and predictive of CVD outcomes; furthermore, it is consistently higher among type 2 diabetics than nondiabetics. However, the relationships of circulating Lp-PLA2 mass and activity with incident type 2 diabetes mellitus have not been examined. Therefore, the purpose of this study was to determine the association of Lp-PLA2 mass and activity with type 2 diabetes among older adults. Methods: We conducted analyses of Lp-PLA2 and prevalent and incident diabetes among 5474 men and women from the Cardiovascular Health Study (1989-2007). Lp-PLA2 mass and activity were measured in baseline plasma. Diabetes status was ascertained annually with medication inventories and repeated blood glucose measurements. Generalized linear and Cox proportional hazards models were used to adjust for confounding factors including body mass index and inflammation. Results: At baseline, the top two quintiles of Lp-PLA2 activity were significantly associated with prevalent type 2 diabetes with a multivariable relative risk = 1.35 [95{\%} confidence interval (CI) = 1.11-1.63] for quintile 4, and relative risk = 1.33 (95{\%} CI = 1.07-1.66) for quintile 5. Among participants free of diabetes at baseline, we found a significant positive association with both the homeostatic model assessment for insulin resistance and β-cell function per sd increase in Lp-PLA2 activity (P values for both <0.01). In prospective analyses, the risk of incident type 2 diabetes was significantly higher among those in the highest quintile of Lp-PLA2 activity [multivariable hazard ratio = 1.45 (95{\%} CI = 1.01-2.07)] compared with the lowest quintile. Lp-PLA2 mass was not significantly associated with incident type 2 diabetes. Discussion: Lp-PLA2 activity is positively associated with insulin resistance and predicts incident type 2 diabetes among older adults independent of multiple factors associated with diabetes pathogenesis.",
author = "Nelson, {T. L.} and Biggs, {M. L.} and Jorge Kizer and M. Cushman and Hokanson, {J. E.} and Furberg, {C. D.} and Mukamal, {K. J.}",
year = "2012",
month = "5",
doi = "10.1210/jc.2011-3026",
language = "English (US)",
volume = "97",
pages = "1695--1701",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Lipoprotein-associated phospholipase A2 (Lp-PLA2) and future risk of type 2 diabetes

T2 - Results from the Cardiovascular Health Study

AU - Nelson, T. L.

AU - Biggs, M. L.

AU - Kizer, Jorge

AU - Cushman, M.

AU - Hokanson, J. E.

AU - Furberg, C. D.

AU - Mukamal, K. J.

PY - 2012/5

Y1 - 2012/5

N2 - Introduction: Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been consistently associated with cardiovascular disease (CVD) risk factors and predictive of CVD outcomes; furthermore, it is consistently higher among type 2 diabetics than nondiabetics. However, the relationships of circulating Lp-PLA2 mass and activity with incident type 2 diabetes mellitus have not been examined. Therefore, the purpose of this study was to determine the association of Lp-PLA2 mass and activity with type 2 diabetes among older adults. Methods: We conducted analyses of Lp-PLA2 and prevalent and incident diabetes among 5474 men and women from the Cardiovascular Health Study (1989-2007). Lp-PLA2 mass and activity were measured in baseline plasma. Diabetes status was ascertained annually with medication inventories and repeated blood glucose measurements. Generalized linear and Cox proportional hazards models were used to adjust for confounding factors including body mass index and inflammation. Results: At baseline, the top two quintiles of Lp-PLA2 activity were significantly associated with prevalent type 2 diabetes with a multivariable relative risk = 1.35 [95% confidence interval (CI) = 1.11-1.63] for quintile 4, and relative risk = 1.33 (95% CI = 1.07-1.66) for quintile 5. Among participants free of diabetes at baseline, we found a significant positive association with both the homeostatic model assessment for insulin resistance and β-cell function per sd increase in Lp-PLA2 activity (P values for both <0.01). In prospective analyses, the risk of incident type 2 diabetes was significantly higher among those in the highest quintile of Lp-PLA2 activity [multivariable hazard ratio = 1.45 (95% CI = 1.01-2.07)] compared with the lowest quintile. Lp-PLA2 mass was not significantly associated with incident type 2 diabetes. Discussion: Lp-PLA2 activity is positively associated with insulin resistance and predicts incident type 2 diabetes among older adults independent of multiple factors associated with diabetes pathogenesis.

AB - Introduction: Lipoprotein-associated phospholipase A2 (Lp-PLA2) has been consistently associated with cardiovascular disease (CVD) risk factors and predictive of CVD outcomes; furthermore, it is consistently higher among type 2 diabetics than nondiabetics. However, the relationships of circulating Lp-PLA2 mass and activity with incident type 2 diabetes mellitus have not been examined. Therefore, the purpose of this study was to determine the association of Lp-PLA2 mass and activity with type 2 diabetes among older adults. Methods: We conducted analyses of Lp-PLA2 and prevalent and incident diabetes among 5474 men and women from the Cardiovascular Health Study (1989-2007). Lp-PLA2 mass and activity were measured in baseline plasma. Diabetes status was ascertained annually with medication inventories and repeated blood glucose measurements. Generalized linear and Cox proportional hazards models were used to adjust for confounding factors including body mass index and inflammation. Results: At baseline, the top two quintiles of Lp-PLA2 activity were significantly associated with prevalent type 2 diabetes with a multivariable relative risk = 1.35 [95% confidence interval (CI) = 1.11-1.63] for quintile 4, and relative risk = 1.33 (95% CI = 1.07-1.66) for quintile 5. Among participants free of diabetes at baseline, we found a significant positive association with both the homeostatic model assessment for insulin resistance and β-cell function per sd increase in Lp-PLA2 activity (P values for both <0.01). In prospective analyses, the risk of incident type 2 diabetes was significantly higher among those in the highest quintile of Lp-PLA2 activity [multivariable hazard ratio = 1.45 (95% CI = 1.01-2.07)] compared with the lowest quintile. Lp-PLA2 mass was not significantly associated with incident type 2 diabetes. Discussion: Lp-PLA2 activity is positively associated with insulin resistance and predicts incident type 2 diabetes among older adults independent of multiple factors associated with diabetes pathogenesis.

UR - http://www.scopus.com/inward/record.url?scp=84860711792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860711792&partnerID=8YFLogxK

U2 - 10.1210/jc.2011-3026

DO - 10.1210/jc.2011-3026

M3 - Article

C2 - 22399516

AN - SCOPUS:84860711792

VL - 97

SP - 1695

EP - 1701

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -